DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,350.00
+160.00 (2.58%)
At close: Sep 4, 2026

DuChemBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
41,50938,57235,60134,695
Revenue Growth
15.90%8.35%2.61%-
Gross Profit
15,69614,23012,23411,797
Operating Income
8,0737,4435,0765,256
Net Income
6,8276,4807,9944,001
Earnings Per Share
239.83228.00297.54149.54
EPS Growth
-8.69%-23.37%98.97%-

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
South Korea
38,46035,55534,592
North America
18.025.3759.79
Oceania
58.8322.0513.28
Asia
35.6818.0930.72
Total
38,57235,60134,695

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
19,02815,45010,6901,981
Total Debt
20,74724,45917,55121,755
Net Cash (Debt)
-1,719-9,009-6,861-19,775
Net Cash Growth
----
Net Cash Per Share
-60.40-317.09-255.39-739.20

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
12,6439,9397,0298,441
Capital Expenditures
-732.1-865.67-1,589-1,147
Free Cash Flow
11,9119,0745,4407,293
Free Cash Flow Growth
81.45%66.81%-25.41%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
37.81%36.89%34.36%34.00%
Operating Margin
19.45%19.30%14.26%15.15%
Pretax Margin
17.28%17.26%15.63%11.68%
Profit Margin
16.45%16.80%22.45%11.53%
FCF Margin
28.70%23.52%15.28%21.02%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PE Ratio
26.4841.6429.0137.10
Forward PE
-15.80--
P/FCF Ratio
15.1329.7442.6320.35
PS Ratio
4.347.006.514.28